US Stock MarketDetailed Quotes

Immunovant (IMVT)

Watchlist
  • 28.650
  • -0.410-1.41%
Close May 12 15:59 ET
  • 28.650
  • 0.0000.00%
Post 16:15 ET
5.83BMarket Cap-10.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immunovant (IMVT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.03%-92.33M
-15.64%-102.52M
-54.08%-117.41M
-75.46%-375.87M
-85.32%-110.64M
-113.15%-100.39M
-47.60%-88.65M
-60.86%-76.2M
-13.83%-214.23M
-7.00%-59.7M
Net income from continuing operations
0.44%-110.64M
-15.93%-126.5M
-38.40%-120.61M
-59.58%-413.84M
-41.33%-106.45M
-116.11%-111.12M
-86.01%-109.12M
-17.87%-87.15M
-22.93%-259.34M
-26.73%-75.32M
Depreciation and amortization
2.02%101K
17.98%105K
33.75%107K
63.20%377K
70.31%109K
70.69%99K
58.93%89K
50.94%80K
19.69%231K
18.52%64K
Other non cash items
8.70%25K
9.09%24K
-63.64%24K
-88.23%133K
-91.27%22K
-92.20%23K
-92.49%22K
-77.24%66K
-0.09%1.13M
-12.20%252K
Change In working capital
624.35%5.47M
36.93%10.5M
-482.60%-15.44M
-557.10%-12.03M
-384.55%-16.01M
83.32%-1.04M
162.46%7.67M
-117.06%-2.65M
124.25%2.63M
232.42%5.63M
-Change in receivables
261.93%319K
-106.00%-25K
-95.59%129K
165.18%2.97M
95.73%-176K
-174.06%-197K
174.33%417K
2,161.27%2.93M
-137.28%-4.56M
-990.06%-4.12M
-Change in prepaid assets
154.76%2.87M
124.81%1.16M
126.93%498K
-1,832.35%-26.99M
-78.56%-15.21M
-284.73%-5.24M
-359.10%-4.69M
-122.38%-1.85M
107.59%1.56M
-36.59%-8.52M
-Change in payables and accrued expense
-39.97%2.32M
-54.06%9.19M
-294.45%-14.71M
191.92%19.86M
-101.55%-287K
142.70%3.86M
292.66%20.01M
-148.31%-3.73M
586.00%6.8M
919.37%18.52M
-Change in other current assets
-107.17%-38K
102.07%167K
---1.36M
---7.74M
---195K
--530K
---8.07M
--0
--0
--0
-Change in other current liabilities
----
----
----
88.23%-138K
91.09%-23K
92.53%-23K
92.46%-23K
77.08%-69K
-2.36%-1.17M
11.64%-258K
Cash from discontinued investing activities
Operating cash flow
8.03%-92.33M
-15.64%-102.52M
-54.08%-117.41M
-75.46%-375.87M
-85.32%-110.64M
-113.15%-100.39M
-47.60%-88.65M
-60.86%-76.2M
-13.83%-214.23M
-7.00%-59.7M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-110.83%-759K
-34.00%-201K
-37.40%-180K
-476.47%-196K
-304.44%-182K
-82.74%-360K
-476.92%-150K
Net PPE purchase and sale
--0
--0
--0
-110.83%-759K
-34.00%-201K
-37.40%-180K
-476.47%-196K
-304.44%-182K
-82.74%-360K
-476.92%-150K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-110.83%-759K
-34.00%-201K
-37.40%-180K
-476.47%-196K
-304.44%-182K
-82.74%-360K
-476.92%-150K
Financing cash flow
Cash flow from continuing financing activities
22,814.08%564.6M
3,269.18%24.6M
325.36%2.92M
-3.80%454.49M
29,065.83%450.61M
-99.48%2.46M
393.24%730K
-22.92%686K
566.47%472.43M
563.09%1.55M
Net common stock issuance
----
----
----
-4.81%450M
--450M
----
----
----
570.56%472.75M
--0
Proceeds from stock option exercised by employees
752.07%21M
3,269.18%24.6M
325.36%2.92M
-15.51%4.81M
-39.74%931K
-20.80%2.46M
393.24%730K
-22.92%686K
766.67%5.69M
563.09%1.55M
Net other financing activities
----
----
----
94.69%-319K
----
----
----
----
-2,110.29%-6.01M
--0
Cash from discontinued financing activities
Financing cash flow
22,814.08%564.6M
3,269.18%24.6M
325.36%2.92M
-3.80%454.49M
29,065.83%450.61M
-99.48%2.46M
393.24%730K
-22.92%686K
566.47%472.43M
563.09%1.55M
Net cash flow
Beginning cash position
10.35%521.87M
6.95%598.91M
12.37%713.97M
68.74%635.37M
-45.77%374.69M
75.21%472.94M
69.72%560.01M
68.74%635.37M
-23.75%376.53M
59.71%690.94M
Current changes in cash
581.39%472.28M
11.57%-77.92M
-51.26%-114.49M
-69.80%77.86M
682.76%339.77M
-123.21%-98.11M
-46.99%-88.11M
-62.70%-75.7M
319.43%257.84M
-4.89%-58.3M
Effect of exchange rate changes
353.02%377K
-16.30%878K
-268.96%-566K
-24.77%747K
-117.86%-488K
90.72%-149K
1,319.77%1.05M
812.77%335K
351.36%993K
657.55%2.73M
End cash Position
165.43%994.53M
10.35%521.87M
6.95%598.91M
12.37%713.97M
12.37%713.97M
-45.77%374.69M
75.21%472.94M
69.72%560.01M
68.74%635.37M
68.74%635.37M
Free cash flow
8.20%-92.33M
-15.39%-102.52M
-53.72%-117.41M
-75.52%-376.63M
-85.20%-110.84M
-112.94%-100.57M
-47.84%-88.84M
-61.09%-76.38M
-13.91%-214.59M
-7.22%-59.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.03%-92.33M-15.64%-102.52M-54.08%-117.41M-75.46%-375.87M-85.32%-110.64M-113.15%-100.39M-47.60%-88.65M-60.86%-76.2M-13.83%-214.23M-7.00%-59.7M
Net income from continuing operations 0.44%-110.64M-15.93%-126.5M-38.40%-120.61M-59.58%-413.84M-41.33%-106.45M-116.11%-111.12M-86.01%-109.12M-17.87%-87.15M-22.93%-259.34M-26.73%-75.32M
Depreciation and amortization 2.02%101K17.98%105K33.75%107K63.20%377K70.31%109K70.69%99K58.93%89K50.94%80K19.69%231K18.52%64K
Other non cash items 8.70%25K9.09%24K-63.64%24K-88.23%133K-91.27%22K-92.20%23K-92.49%22K-77.24%66K-0.09%1.13M-12.20%252K
Change In working capital 624.35%5.47M36.93%10.5M-482.60%-15.44M-557.10%-12.03M-384.55%-16.01M83.32%-1.04M162.46%7.67M-117.06%-2.65M124.25%2.63M232.42%5.63M
-Change in receivables 261.93%319K-106.00%-25K-95.59%129K165.18%2.97M95.73%-176K-174.06%-197K174.33%417K2,161.27%2.93M-137.28%-4.56M-990.06%-4.12M
-Change in prepaid assets 154.76%2.87M124.81%1.16M126.93%498K-1,832.35%-26.99M-78.56%-15.21M-284.73%-5.24M-359.10%-4.69M-122.38%-1.85M107.59%1.56M-36.59%-8.52M
-Change in payables and accrued expense -39.97%2.32M-54.06%9.19M-294.45%-14.71M191.92%19.86M-101.55%-287K142.70%3.86M292.66%20.01M-148.31%-3.73M586.00%6.8M919.37%18.52M
-Change in other current assets -107.17%-38K102.07%167K---1.36M---7.74M---195K--530K---8.07M--0--0--0
-Change in other current liabilities ------------88.23%-138K91.09%-23K92.53%-23K92.46%-23K77.08%-69K-2.36%-1.17M11.64%-258K
Cash from discontinued investing activities
Operating cash flow 8.03%-92.33M-15.64%-102.52M-54.08%-117.41M-75.46%-375.87M-85.32%-110.64M-113.15%-100.39M-47.60%-88.65M-60.86%-76.2M-13.83%-214.23M-7.00%-59.7M
Investing cash flow
Cash flow from continuing investing activities 000-110.83%-759K-34.00%-201K-37.40%-180K-476.47%-196K-304.44%-182K-82.74%-360K-476.92%-150K
Net PPE purchase and sale --0--0--0-110.83%-759K-34.00%-201K-37.40%-180K-476.47%-196K-304.44%-182K-82.74%-360K-476.92%-150K
Cash from discontinued investing activities
Investing cash flow --0--0--0-110.83%-759K-34.00%-201K-37.40%-180K-476.47%-196K-304.44%-182K-82.74%-360K-476.92%-150K
Financing cash flow
Cash flow from continuing financing activities 22,814.08%564.6M3,269.18%24.6M325.36%2.92M-3.80%454.49M29,065.83%450.61M-99.48%2.46M393.24%730K-22.92%686K566.47%472.43M563.09%1.55M
Net common stock issuance -------------4.81%450M--450M------------570.56%472.75M--0
Proceeds from stock option exercised by employees 752.07%21M3,269.18%24.6M325.36%2.92M-15.51%4.81M-39.74%931K-20.80%2.46M393.24%730K-22.92%686K766.67%5.69M563.09%1.55M
Net other financing activities ------------94.69%-319K-----------------2,110.29%-6.01M--0
Cash from discontinued financing activities
Financing cash flow 22,814.08%564.6M3,269.18%24.6M325.36%2.92M-3.80%454.49M29,065.83%450.61M-99.48%2.46M393.24%730K-22.92%686K566.47%472.43M563.09%1.55M
Net cash flow
Beginning cash position 10.35%521.87M6.95%598.91M12.37%713.97M68.74%635.37M-45.77%374.69M75.21%472.94M69.72%560.01M68.74%635.37M-23.75%376.53M59.71%690.94M
Current changes in cash 581.39%472.28M11.57%-77.92M-51.26%-114.49M-69.80%77.86M682.76%339.77M-123.21%-98.11M-46.99%-88.11M-62.70%-75.7M319.43%257.84M-4.89%-58.3M
Effect of exchange rate changes 353.02%377K-16.30%878K-268.96%-566K-24.77%747K-117.86%-488K90.72%-149K1,319.77%1.05M812.77%335K351.36%993K657.55%2.73M
End cash Position 165.43%994.53M10.35%521.87M6.95%598.91M12.37%713.97M12.37%713.97M-45.77%374.69M75.21%472.94M69.72%560.01M68.74%635.37M68.74%635.37M
Free cash flow 8.20%-92.33M-15.39%-102.52M-53.72%-117.41M-75.52%-376.63M-85.20%-110.84M-112.94%-100.57M-47.84%-88.84M-61.09%-76.38M-13.91%-214.59M-7.22%-59.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -